Michael Craig Pine serves as Executive at EyePoint Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael Craig Pine has executed 8 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 6, 2024 involved selling 5,966 shares valued at $121.7K.
Michael Craig Pine currently holds 13,662 shares of EyePoint Pharmaceuticals, Inc. (EYPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Craig Pine has been a net seller of EYPT stock. They have purchased $12.2K and sold $2.0M worth of shares.
Michael Craig Pine's most recent insider trade was on Jan 6, 2024, when they sold 5,966 shares at $20.40 per share.
Get notified when new Form 4 filings are submitted
| 15,285 |
| $N/A |
| Discretionary |
| Dec 4, 2023 | EYPT | $990.0K | Sale | 45,000 | $22.00 | Planned |
| Dec 4, 2023 | EYPT | $567.9K | Option Exercise | 45,000 | $12.62 | Planned |
| Dec 4, 2023 | EYPT | $990.0K | Sale | 45,000 | $22.00 | Planned |
| Dec 4, 2023 | EYPT | $567.9K | Option Exercise | 45,000 | $12.62 | Planned |
| Dec 4, 2023 | EYPT | $20.8K | Sale | 1,000 | $20.79 | Planned |
| Mar 14, 2022 | EYPT | $12.2K | Purchase | 1,000 | $12.21 | Discretionary |